Releases

TitleDateSizeView
Results of 2021 Annual Meeting of StockholdersMay 11, 2021261 KB Download
Strong quarter for Osprey with continued growth in units and revenueApril 22, 2021619 KB Download
Notice of Annual Meeting of StockholdersApril 20, 2021618 KB Download
Quarterly Results and Investor Conference Call NotificationApril 16, 2021217 KB Download
CEO Business Update Investor PresentationApril 16, 202118 MB Download
Appendix 4G Key to Disclosures Corporate Governance Council Principles and RecommendationsMarch 30, 2021252 KB Download
Osprey expands US sales coverageMarch 18, 2021360 KB Download
Osprey presents at ASX Small & Mid-Cap Conference and Oppenheimer Healthcare ConferenceMarch 10, 202118 MB Download
Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)March 3, 2021181 KB Download
Osprey expands US sales coverage with new sales agency agreementsMarch 2, 2021432 KB Download
Osprey Medical Financial Results for FY2020February 26, 2021250 KB Download
Funding Update – Exercise of Options and PPP LoanFebruary 23, 2021181 KB Download
Notice of Final Exercise of Options and Underwriting ArrangementsFebruary 12, 2021474 KB Download
4C and Business UpdateJanuary 28, 2021537 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 22, 2021215 KB Download
Osprey Investor PresentationJanuary 12, 202113 MB Download
Osprey Investor PresentationDecember 3, 20202 MB Download
Osprey signs strategic sales agency agreement for new US regionNovember 26, 2020288 KB Download
Strong quarter for Osprey with milestone distribution agreements signedOctober 29, 2020529 KB Download
Exercise of OptionsOctober 21, 2020176 KB Download
Quarterly Results and Investor Conference Call NotificationOctober 21, 2020213 KB Download
Osprey receives Supplier Horizon Award from Premier IncSeptember 29, 2020239 KB Download
Regional Health Care Group to distribute Osprey Medical kidney protection technology across Australia and New ZealandSeptember 24, 2020261 KB Download
Osprey to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember 15, 2020211 KB Download
Notice of Exercise of OptionsSeptember 14, 2020177 KB Download
Positive outlook following adjustments to COVID-19August 25, 2020314 KB Download
Appendix 4D Half-Year Report for the Six Months Ended 30 June 2020August 25, 2020472 KB Download
Resignation of Andy Jane from the Board of DirectorsAugust 18, 2020177 KB Download
CE Marking received for core European product, DyeVert Power XTAugust 13, 2020312 KB Download
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)July 30, 2020257 KB Download
Positive traction in the Quarter that was defined by COVID-19July 28, 2020536 KB Download
Shortfall Placement Update and Quarterly Results Release NotificationJuly 15, 2020227 KB Download
Response to ASX Price QueryJuly 3, 2020303 KB Download
Results of 2020 Annual Meeting of StockholdersJune 19, 2020227 KB Download
2020 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEOJune 19, 202011 MB Download
Issue of Securities under Shortfall PlacementJune 12, 2020176 KB Download
Appendix 2A: Application for quotation of +securitiesJune 12, 2020279 KB Download
Appendix 3G: Notification of issue, conversion or payment up of equity +securitiesJune 12, 2020381 KB Download
Notice of Exercise of OptionsJune 10, 2020368 KB Download
Osprey Medical successfully raises an additional $2.6m under Shortfall PlacementJune 9, 2020179 KB Download
Trading HaltJune 4, 2020365 KB Download
Notice of Annual Meeting of StockholdersMay 29, 20203 MB Download
ASX AnnouncementMay 29, 2020164 KB Download
DyeVert™ featured at the SCAI 2020 Scientific Session: Procedure-Based Strategies to reduce Contrast-Induced Acute Kidney InjuryMay 28, 2020223 KB Download
Allotment of Securities under Entitlement OfferMay 1, 2020118 KB Download
Appendix 2A: Application for quotation of +securitiesMay 1, 2020156 KB Download
Appendix 3G: Notification of issue, conversion or payment up of equity +securitiesMay 1, 2020140 KB Download
Quarterly Results and COVID-19 UpdateApril 30, 2020253 KB Download
Completion of Entitlement OfferApril 29, 2020182 KB Download
Osprey Medical Secures US Government COVID-19 Relief LoanApril 29, 2020175 KB Download
Quarterly Results and Investor Conference Call NotificationApril 17, 2020215 KB Download
ASX ANNOUNCEMENT: 2020 Annual Meeting of StockholdersApril 16, 2020235 KB Download
Dispatch of Prospectus, Entitlement and Acceptance FormsApril 15, 2020785 KB Download
Rights Commence TradingApril 7, 2020184 KB Download
ASX ANNOUNCEMENT: Entitlement Offer – Notification to Ineligible CDI Holders and OptionholdersApril 6, 2020196 KB Download
Amended and Restated Certificate of IncorporationApril 3, 2020634 KB Download
Osprey Medical ProspectusApril 3, 2020489 KB Download
Proposed Issues of SecuritiesApril 3, 202042 KB Download
Osprey Medical Announces Capital Raising and Trading UpdateApril 3, 2020129 KB Download
Trading HaltApril 1, 2020354 KB Download
Appendix 4G Corporate Governance CouncilMarch 26, 2020204 KB Download
ASX ANNOUNCEMENT – 2020 Annual Meeting of StockholdersMarch 26, 2020196 KB Download
4E Cover MemoFebruary 25, 2020103 KB Download
Osprey Medical Financial Results for FY2019February 25, 2020222 KB Download
Appendix 4E (Rule 4.3A): Preliminary Final Report for the Year Ended 31 December 2019February 24, 2020550 KB Download
UK NICE Issues Positive MedTech Innovation Briefing on DyeVert™February 10, 2020229 KB Download
ASX ANNOUNCEMENT – 2020 Annual Meeting of StockholdersFebruary 6, 2020197 KB Download
Appendix 4C: Quarterly report for entities subject to listing rule 7.8BFebruary 5, 202069 KB Download
36% Increase in DyeVert Unit SalesJanuary 31, 2020499 KB Download
Amendment to Quarterly Results and Investor Conference Call NotificationJanuary 21, 2020220 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 10, 2020215 KB Download
Fourth Quarter UpdateDecember 20, 2019223 KB Download
48% Increase in DyeVert Third Quarter Unit SalesOctober 29, 2019459 KB Download
Quarterly Results and Investor Conference Call NotificationOctober 17, 2019275 KB Download
Contrast-Induced Acute Kidney Injury Prevention Strategies Featured at TCT 2019October 3, 2019278 KB Download
Ceasing to be a Substantial HolderSeptember 6, 201965 KB Download
Half Yearly Accounts ReportAugust 14, 2019550 KB Download
Half Year Info for Six Months ended 30 June 2019August 14, 2019622 KB Download
64% Increase in DyeVert Second Quarter Unit SalesJuly 15, 2019262 KB Download
Appendix 4C: Quarterly report for entities subject to Listing Rule 4.7BJuly 15, 2019169 KB Download
US Government to Transform Kidney CareJuly 12, 2019277 KB Download
Osprey Launches Educational Podcast Series for InvestorsJuly 9, 2019179 KB Download
Quarterly Results and Investor Conference Call NotificationJuly 2, 201989 KB Download
AKI Burden of Illness Data Presented at Premier® Breakthroughs ConferenceJune 21, 2019311 KB Download
Becoming a Substantial HolderJune 20, 2019107 KB Download
Ceasing to be a Substantial HolderJune 13, 201989 KB Download
Osprey to Deliver AKI Burden of Illness Data to Premier QUEST® HospitalsJune 13, 2019209 KB Download
2019 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEOMay 9, 201912 MB Download
Results of 2019 Annual Meeting of StockholdersMay 9, 2019344 KB Download
DyeMINISH™ Multi-Centre Global Patient Registry LaunchedMay 8, 2019251 KB Download
Appendix 4C: Quarterly report for entities subject to Listing Rule 4.7BApril 17, 2019169 KB Download
73% Increase in DyeVert First Quarter Unit SalesApril 17, 2019319 KB Download
Notice of Annual Meeting of Stockholders & Proxy StatementApril 11, 20193 MB Download
Quarterly Results and Investor Conference Call NotificationApril 8, 2019237 KB Download
Change in Substantial HoldingApril 3, 2019253 KB Download
Appendix 4GMarch 26, 2019183 KB Download
Significant DyeVert™ Clinical Data Featured at ACC and ACC Quality Summit Annual MeetingsMarch 20, 2019289 KB Download
Osprey Appoints Mr. Jim Surek as Vice President, SalesMarch 4, 2019241 KB Download
Osprey Medical Preliminary Final Report and Consolidated Financial StatementsFebruary 26, 2019879 KB Download
ASX ANNOUNCEMENT – 2019 Annual Meeting of StockholdersFebruary 1, 2019292 KB Download
Quarterly Cash Flow ReportJanuary 29, 2019438 KB Download
Quarterly Results and Investor Conference Call NotificationJanuary 17, 2019307 KB Download
Disclosure of Interests for Allan Gray AustraliaDecember 10, 2018258 KB Download
Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction SystemDecember 3, 2018272 KB Download
Allotment of Securities under Entitlement OfferNovember 30, 2018130 KB Download
Completion of Entitlement OfferNovember 28, 2018291 KB Download
Entitlement Offer – Update on ShortfallNovember 19, 2018289 KB Download
Entitlement Offer – Extension of Closing DateNovember 13, 2018301 KB Download
Osprey Medical – Notice of despatch of entitlement offer documentsNovember 7, 2018852 KB Download
Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations ActNovember 6, 2018347 KB Download
Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)November 6, 2018325 KB Download
Appendix 3B: New issue announcement,
application for quotation of additional securities
and agreement
November 6, 2018403 KB Download
Completion of Private PlacementNovember 6, 2018293 KB Download
Entitlement Offer – Notice to Holders of CDIsOctober 31, 2018382 KB Download
Entitlement Offer – Notification to Ineligible CDI HoldersOctober 31, 2018443 KB Download
Entitlement Offer – Notice to OptionholdersOctober 30, 2018109 KB Download
Capital raising of up to A$20.5m to accelerate GPO-focused growth strategyOctober 30, 2018377 KB Download
Quarterly Cash Flow ReportOctober 30, 2018765 KB Download
Offer BookletOctober 30, 2018301 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementOctober 30, 2018182 KB Download
Notice given under Section 708AA(2)(f) of the Corporations ActOctober 30, 2018148 KB Download
Letter to Option HoldersOctober 30, 2018105 KB Download
Quarterly Results and Investor Conference Call NotificationOctober 25, 2018313 KB Download
Acute Kidney Injury in the spotlight at the world’s largest international cardiovascular conference TCT 2018September 26, 2018101 KB Download
Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI)September 20, 2018406 KB Download
Osprey Medical begins market access process to approve DyeVert™ Plus System in UKSeptember 7, 2018241 KB Download
Half Yearly Accounts ReportAugust 27, 2018344 KB Download
Half Year Info for Six Months ended 30 June 2018August 27, 2018301 KB Download
Quarterly Cash Flow ReportJuly 19, 20181 MB Download
Results of 2018 Annual Meeting of StockholdersMay 10, 2018127 KB Download
2018 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEOMay 10, 20182 MB Download
Strong Recovery for DyeVert Plus in April 2018May 2, 201896 KB Download
DyeVert Plus Featured at SCAI 2018 Scientific SessionApril 30, 20182 MB Download
Quarterly Cash Flow ReportApril 26, 20181.9 MB Download
ASX ANNOUNCEMENT – Notice of 2018 Annual Meeting of Stockholders & Proxy StatementApril 9, 20181 MB Download
Osprey Medical National Kidney Month ProgramsMarch 21, 20181 MB Download
Osprey Medical Preliminary Final Report and Consolidated Financial StatementsFebruary 26, 2018470 KB Download
Osprey Study chosen for “Best of Best” Presentation at Society for Cardiovascular Angiography and Interventions conferenceFebruary 16, 2018141 KB Download
2018 Annual Meeting of Stockholders AnnouncementFebruary 6, 201889 KB Download
Quarterly Cash Flow ReportJanuary 24, 20182 MB Download
Osprey Medical Highlights from TCT 2017November 3, 2017108 KB Download
Quarterly Cash Flow ReportOctober 16, 20171 MB Download
Issue of securities to complete Placement and Entitlement OfferSeptember 4, 201798 KB Download
Osprey Medical Inc. Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations ActSeptember 4, 2017119 KB Download
Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)September 4, 2017126 KB Download
Successful completion of A$10.3 million entitlement offerAugust 30, 2017114 KB Download
Entitlement Offer Closing DateAugust 22, 2017102 KB Download
Half Yearly Accounts ReportAugust 21, 2017188 KB Download
Half Year Information for the Six Months Ended 30 June 2017August 21, 2017205 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementAugust 18, 2017186 KB Download
Osprey Medical Inc. Amended and Restated Certificate of IncorporationAugust 16, 20171 MB Download
Osprey Medical – Notice to NomineesAugust 15, 2017587 KB Download
Osprey Medical – Notice of despatch of entitlement offer documentsAugust 14, 20171,010 KB Download
Osprey Medical Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)August 11, 2017134 KB Download
Private Placement UpdateAugust 11, 2017100 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementAugust 11, 2017204 KB Download
Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations ActAugust 11, 2017121 KB Download
Osprey Entitlement Offer – notification to ineligible CDI holdersAugust 7, 2017625 KB Download
Entitlement Offer – notice to holders of CDIsAugust 7, 2017546 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementAugust 4, 2017197 KB Download
Osprey Medical Announces Successful Oversubscribed Placement and Fully Underwritten Entitlement OfferAugust 4, 2017149 KB Download
Osprey Medical Inc. Entitlement Offer – Notice to OptionholdersAugust 4, 2017112 KB Download
Osprey Medical Inc. Offer BookletAugust 4, 2017381 KB Download
Cleansing DocumentAugust 4, 2017182 KB Download
Capital Raising Presentation, August 2017August, 20173.3 MB Download
Capital Raise Trading HaltAugust 2, 2017334 KB Download
Quarterly Cash Flow ReportJuly 13, 20171 MB Download
Osprey Medical increases addressable market with new DyeTect™ Automated Contrast Monitoring SystemJuly 3, 2017156 KB Download
Medtronic VP and GM Sandra Lesenfants Joins Osprey BoardJune 20, 2017137 KB Download
ASX ANNOUNCEMENT – Results of 2017 Annual Meeting of StockholdersMay 18, 2017137 KB Download
ASX ANNOUNCEMENT – 2017 Annual Meeting of Stockholders – Chairman’s Address and Presentation by President and CEOMay 18, 20175 MB Download
Quarterly Cash Flow ReportApril 18, 20172 MB Download
Osprey Medical Receives US FDA Clearance for DyeVert™ PLUSMarch 9, 2017371 KB Download
ASX ANNOUNCEMENT – Notice of Annual Meeting of Stockholders & Proxy StatementApril 24, 2017963 KB Download
Preliminary Final Report and Consolidated Financial AccountsFebruary 27, 2017290 KB Download
CEO Presentation December 2016December 20162 MB Download
Osprey Introduces DyeVert PLUS at TCTNovember 2, 2016370 KB Download
Osprey to Present at TCT 2016October 26, 2016288 KB Download
4C Quarterly Cash Flow ReportOctober 14, 20162 MB Download
ASX ANNOUNCEMENT – Completion of Private PlacementSeptember 9, 201692 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementSeptember 9, 2016219 KB Download
Change of Melbourne Address for Shareholder PurposesSeptember 9, 2016108 KB Download
Form 604: Notice of Change of Interests of Substantial HolderSeptember 9, 2016331 KB Download
Brandon Capital Partners – Change in Substantial HoldingSeptember 9, 2016213 KB Download
Secondary Trading Notice: Notice given under Section 708A(5)(e) of the Corporations ActSeptember 9, 2016114 KB Download
ASX ANNOUNCEMENT – Security Purchase Plan Scale BackSeptember 7, 2016107 KB Download
ASX ANNOUNCEMENT – Partial Allocation Under Tranche 2 of Placement and Security Purchase Plan UpdateSeptember 6, 2016104 KB Download
Notice Given Under Section 708A(5)(e) of the Corporations ActSeptember 6, 2016113 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementSeptember 6, 2016207 KB Download
Results of Special Meeting of StockholdersAugust 30, 2016136 KB Download
Half Year Accounts ReportAugust 29, 2016518 KB Download
Appendix 4D Half Year Report & AccountsAugust 26, 2016195 KB Download
Notice of Special Meeting of StockholdersAugust 18, 2016452 KB Download
Cleansing DocumentAugust 11, 2016121 KB Download
Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)August 11, 2016107 KB Download
Appendix 3B: New issue announcement, application for quotation of additional securities and agreementAugust 11, 2016216 KB Download
Share Purchase PlanAugust 3, 2016619 KB Download
Revised CEO Capital Raising PresentationAugust 4, 20162 MB Download
Capital Raising Presentation, August 2016August 20165 MB Download
Amended and Restated Certificate of IncorporationAugust 4, 20161 MB Download
Osprey Medical Announces Oversubscribed A$28 Million Private PlacementAugust 4, 2016124 KB Download
Response to ASX Price QueryJuly 29, 2016500 KB Download
CommSec Interview with CEO Mike McCormickJuly 27, 2016241 KB Download
Key Sales MilestonesJuly 7, 2016108 KB Download
DyeVert Pilot Results presented at EuroPCRMay 20, 2016215 KB Download
2016 AGM ResultsMay 12, 2016137 KB Download
June 2016 NewsletterJune 20162 MB Download
AGM Chairman’s letter and CEO presentationMay 12, 20165 MB Download